SciELO - Scientific Electronic Library Online

 
vol.57 número2Trasplante de células progenitoras hematopoyéticas en síndromes mielodisplásicosTrasplante de células progenitoras hematopoyéticas en anemia aplástica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista de investigación clínica

versión impresa ISSN 0034-8376

Resumen

GOMEZ-ALMAGUER, David; RUIZ-ARGUELLES, Guillermo J.; GUTIERREZ-AGUIRRE, César H.  y  JAIME-PEREZ, José C.. Non-myeloablative transplant of hematopoyetic precursor cells: Myth and reality. Rev. invest. clín. [online]. 2005, vol.57, n.2, pp.291-297. ISSN 0034-8376.

The feasibility of applying allogeneic cell -mediated therapy in conjunction with allogeneic hematopoietic cell transplantation following reduced -intensity conditioning, with minimal toxicity and no serious transplant-related complications, makes it possible to perform such procedures on an outpatient basis as well to offer a valid option for cure to elderly individuals and patients with less than optimal performance status. Based on available experience, clinical application of this innovative therapy may open new horizons for the treatment of patients with leukemia, lymphoma, myeloma and other diseases. Many patients can now benefit from the advantages of immunotherapy mediated by alloreactive donor lymphocytes, while minimizing transplant-related toxicity and mortality. This kind of transplant is making real progress in the world of transplantation.

Palabras llave : Allogeneic; Reduced-intensity; Conditioning hematopoietic cell.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons